Premium
Novel L2HGDH mutations in 21 patients with L‐2‐hydroxyglutaric aciduria of Portuguese origin
Author(s) -
Vilarinho L.,
Cardoso M.L.,
Gaspar P.,
Barbot C.,
Azevedo L.,
Diogo L.,
Santos M.,
Carrilho I.,
Fineza I.,
Kok F.,
Chorão R.,
Alegria P.,
Martins E.,
Teixeira J.,
Cabral Fernandes H.,
Verhoeven N.M.,
Salomons G.S.,
Santorelli F.M.,
Cabral P.,
Amorim A.,
Jakobs C.
Publication year - 2005
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.9373
Subject(s) - biology , portuguese , genetics , mutation , computational biology , gene , linguistics , philosophy
We studied 21 patients, from 18 families, with L‐2‐hydroxyglutaric aciduria (L‐2‐HGA), a rare neurometabolic disorder with a homogeneous presentation: progressive neurodegeneration with extrapyramidal and cerebellar signs, seizures, and subcortical leukoencephalopathy. Increased levels of L‐2‐hydroxyglutaric acid in body fluids proved the diagnosis of L‐2‐HGA in all 21 patients. We analyzed the L‐2‐HGA gene (L2HGDH), recently found to be mutated in consanguineous families with L‐2‐HGA, and identified seven novel mutations in 15 families. Three mutations appeared to be particularly prevalent in this Portuguese panel: a frameshift mutation (c.529delC) was detected in 12 out of 30 mutant alleles (40%), a nonsense mutation (c.208C>T; p.Arg70X) in 7/30 alleles (23%), and a missense mutation (c.293A>G; p.His98Arg) in four out of 30 mutant alleles (13%), suggesting that common origin may exist. Furthermore, two novel missense (c.169G>A; p.Gly57Arg, c.1301A>C; p.His434Pro) and two splice error (c.257‐2A>G, c.907‐2A>G) mutations were found. All the mutations presumably lead to loss‐of‐function with no relationship between clinical signs, progression of the disease, levels of L‐2‐HGA and site of the mutation. In the three remaining families, no pathogenic mutations in the L‐2‐HGA were found, which suggests either alterations in regulatory regions of the gene or of its intervening sequences, compound heterozygosity for large genomic deletion and, or further genetic heterogeneity. © 2005 Wiley‐Liss, Inc.